Squarepoint Ops LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $561,144 - $688,824	2,400 Added 200.0%	3,600 $990,000
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $2.69 Million - $4.64 Million	-18,800 Reduced 94.0%	1,200 $291,000
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $2.93 Million - $3.96 Million	20,000 New	20,000 $2.99 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $322,525 - $394,687	-1,900 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $8.07 Million - $11.1 Million	-62,700 Reduced 97.06%	1,900 $322,000
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $8.19 Million - $11.3 Million	64,600 New	64,600 $9.12 Million

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.